ES2733282T3 - Forma farmacéutica de dietilestilbestrol y uso para el tratamiento de cáncer de próstata o mama - Google Patents

Forma farmacéutica de dietilestilbestrol y uso para el tratamiento de cáncer de próstata o mama Download PDF

Info

Publication number
ES2733282T3
ES2733282T3 ES12709150T ES12709150T ES2733282T3 ES 2733282 T3 ES2733282 T3 ES 2733282T3 ES 12709150 T ES12709150 T ES 12709150T ES 12709150 T ES12709150 T ES 12709150T ES 2733282 T3 ES2733282 T3 ES 2733282T3
Authority
ES
Spain
Prior art keywords
diethylstilbestrol
sucrose
des
matrix
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12709150T
Other languages
English (en)
Spanish (es)
Inventor
Diana Shu-Lian Chow
Roland A Ako
Je Phil Ryoo
Chun Kwong Chu
Zheng Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nal Pharmaceutical Group Ltd
Original Assignee
Nal Pharmaceutical Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nal Pharmaceutical Group Ltd filed Critical Nal Pharmaceutical Group Ltd
Application granted granted Critical
Publication of ES2733282T3 publication Critical patent/ES2733282T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES12709150T 2011-03-03 2012-03-02 Forma farmacéutica de dietilestilbestrol y uso para el tratamiento de cáncer de próstata o mama Active ES2733282T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/040,143 US8900634B2 (en) 2008-11-03 2011-03-03 Diethylstilbestrol dosage form and methods of treatment using thereof
PCT/GB2012/050475 WO2012117257A1 (en) 2011-03-03 2012-03-02 Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer

Publications (1)

Publication Number Publication Date
ES2733282T3 true ES2733282T3 (es) 2019-11-28

Family

ID=45841525

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12709150T Active ES2733282T3 (es) 2011-03-03 2012-03-02 Forma farmacéutica de dietilestilbestrol y uso para el tratamiento de cáncer de próstata o mama

Country Status (13)

Country Link
US (1) US8900634B2 (enExample)
EP (1) EP2680813B1 (enExample)
JP (2) JP6059153B2 (enExample)
KR (1) KR101865776B1 (enExample)
CN (1) CN103561720A (enExample)
AU (2) AU2012223023B2 (enExample)
BR (1) BR112013022438A2 (enExample)
CA (1) CA2827892C (enExample)
ES (1) ES2733282T3 (enExample)
RU (1) RU2602296C2 (enExample)
SG (1) SG192845A1 (enExample)
TW (1) TWI548426B (enExample)
WO (1) WO2012117257A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8715715B2 (en) * 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
US8900634B2 (en) * 2008-11-03 2014-12-02 Nal Pharmaceuticals, Ltd. Diethylstilbestrol dosage form and methods of treatment using thereof
MX2015004759A (es) * 2012-10-15 2015-10-12 Chamaeleo Pharma Bvba Fosfestrol para uso en el tratamiento curativo o paliativo de cancer en mamiferos hembras.
EP2906206A1 (en) 2012-10-15 2015-08-19 CHAMAELEO Pharma Bvba Sulfestrol for treating cancer
CA2888161A1 (en) 2012-10-15 2014-04-24 Chamaeleo Pharma Bvba Fosfestrol for use in curative or palliative treatment of prostate cancer
SG11201610358XA (en) 2014-06-24 2017-01-27 Catherine Lee Fast acting orally disintegrating film
CN105997857A (zh) * 2016-06-29 2016-10-12 冯志清 一种用于治疗猪乳房炎的注射液
WO2018091473A1 (en) 2016-11-15 2018-05-24 Klaria Pharma Holding Ab Pharmaceutical formulation
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
KR101940401B1 (ko) * 2017-06-12 2019-01-21 경상대학교산학협력단 맛이 차폐된 구강붕해필름 및 이의 제조방법
WO2019028457A2 (en) * 2017-08-04 2019-02-07 University Of Houston System FORMULATION OF NANOSUSPENSION OF DIETHYLSTILBESTROL INJECTABLE
GB201808462D0 (en) 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
WO2020030991A1 (en) * 2018-08-09 2020-02-13 Nal Pharmaceutical Group Limited Dosage form for insertion into the mouth
CN113133983B (zh) * 2020-01-20 2023-12-12 鲁南制药集团股份有限公司 一种治疗前列腺癌的药物组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026560A (en) 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US5464632C1 (en) 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
KR100554924B1 (ko) 1998-05-18 2006-03-03 다케다 야쿠힌 고교 가부시키가이샤 구강내 붕괴 정제
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20020015730A1 (en) * 2000-03-09 2002-02-07 Torsten Hoffmann Pharmaceutical formulations and method for making
US20030147936A1 (en) 2002-02-07 2003-08-07 Velayudhan Sahadevan Prostatic hormonal implants treatment of prostate cancer
PE20060003A1 (es) * 2004-03-12 2006-03-01 Smithkline Beecham Plc Formulacion farmaceutica polimerica para moldear por inyeccion
IL175338A0 (en) * 2006-05-01 2006-09-05 Biota Ltd Orally administrable films and preparation thereof
WO2008045461A2 (en) * 2006-10-11 2008-04-17 Oregon Health & Science University Transdermal diethylstilbestrol for treating prostate cancer
AU2008237246B2 (en) * 2007-04-05 2014-06-05 University Of Kansas Rapidly dissolving pharmaceutical compositions comprising pullulan
WO2009029543A1 (en) 2007-08-24 2009-03-05 Aegis Therapeutics, Llc Controlled release formulations
US8900634B2 (en) * 2008-11-03 2014-12-02 Nal Pharmaceuticals, Ltd. Diethylstilbestrol dosage form and methods of treatment using thereof
US8715715B2 (en) * 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth

Also Published As

Publication number Publication date
EP2680813A1 (en) 2014-01-08
JP6059153B2 (ja) 2017-01-11
BR112013022438A2 (pt) 2016-12-06
EP2680813B1 (en) 2019-05-08
CN103561720A (zh) 2014-02-05
SG192845A1 (en) 2013-09-30
RU2602296C2 (ru) 2016-11-20
TW201249484A (en) 2012-12-16
US20110189288A1 (en) 2011-08-04
AU2017203009A1 (en) 2017-05-25
RU2013144383A (ru) 2015-04-10
WO2012117257A8 (en) 2013-09-19
KR20140021587A (ko) 2014-02-20
WO2012117257A1 (en) 2012-09-07
KR101865776B1 (ko) 2018-06-08
US8900634B2 (en) 2014-12-02
JP2017061465A (ja) 2017-03-30
TWI548426B (zh) 2016-09-11
JP2014506914A (ja) 2014-03-20
AU2012223023B2 (en) 2017-03-16
CA2827892C (en) 2019-12-03
AU2017203009B2 (en) 2018-07-19
AU2012223023A1 (en) 2013-09-19
CA2827892A1 (en) 2012-09-07

Similar Documents

Publication Publication Date Title
ES2733282T3 (es) Forma farmacéutica de dietilestilbestrol y uso para el tratamiento de cáncer de próstata o mama
ES2968132T3 (es) Preparación farmacéutica de palbociclib y uso médico de la misma
ES2731601T3 (es) Composiciones de dosificación oral de liberación retardada que contienen CDDO-Me amorfo
JP5213446B2 (ja) ジクロフェナクを含む医薬組成物
US20240122846A1 (en) Pharmaceutical composition comprising an androgen receptor inhibitor
CA2549966A1 (en) Drug-containing nanoparticle, process for producing the same and parenterally administered preparation from the nanoparticle
WO2009069139A1 (en) Dosage form providing an ibuprofen-containing liquid fill
EP2838510A1 (en) Atomoxetine solution
US11179331B1 (en) Oral soluble film containing sildenafil citrate
CA2891362A1 (en) Effervescent tablet
WO2017190714A1 (es) Compuesto fenólico y combinación del mismo con una benzodiazepina fusionada a 1,4-dihidropiridina para el tratamiento de afecciones del sistema nervioso central y vascular
CH707354A1 (fr) Composition pharmaceutique sous la forme d'une suspension orale comprenant une fraction flavonoïque et de la gomme xanthane.
WO2019162756A2 (en) Liquid pharmaceutical compositions of anticancer drugs
JP2001240558A (ja) 多価不飽和脂肪酸を経粘膜吸収促進剤として含有する固形製剤。
WO2005046651A1 (en) Liquid filled capsules of doxycycline
HK1192153A (en) Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer
ES2717470T3 (es) Formulaciones de obleas y cápsulas con velocidades de disolución aumentadas para fenofibrato
CN118252797A (zh) 一种布地奈德黏性口服溶液、制备方法及其应用
CN118021829A (zh) 一种水溶性的维生素d3组合物及其制备方法
US20190008843A1 (en) Pharmaceutical compositions for on demand anticoagulant therapy
CA3213461A1 (en) Phospholipids as anion chelating agents in pharmaceutical formulations